American Academy of Neurology Archives

Representatives Morgan Griffitth (R-Virginia) and Earl Blumenauer (D-Oregon) filed federal legislation this week that would reschedule cannabis and cannabidiol (CBD).

Specifically, the Compassionate Access Act would “reschedule marijuana from its current position as a Schedule 1 drug under the Controlled Substances Act, which asserts the drug has no medical use and limits the ability of researchers to study the drug’s safety and effectiveness as a treatment”. This would “allow the states to provide appropriate access to patients needing these legitimate, medical treatments under the supervision of their physician”.

According to a press release, the proposal is supported by the Epilepsy Foundation, the American Academy of Neurology, and Americans for Safe Access.